The Lagos State University Teaching Hospital (LASUTH), says it has begun conducting research on four drugs for the treatment of COVID-19 patients.
The Chief Medical Director of the hospital, Prof. Adetokunbo Fabamwo disclosed this in a statement, while updating the public on the hospital’s role in eradicating the COVID-19.
He said the research focuses on coagulation factors and COVID-19, the role of multi-morbidity and multi-organ dysfunction in COVID-19.
“The hospital is poised to carry out these studies, for which external and internal funding is already being sought.
“The commissioner for health has been informed about this.
“However, two things needed to happen; our gene expert machine needs to be adapted and reagents kits need to be provided for the tests.
The architecture of the wards in LASUTH is of the cottage hospital type.
“The wards are interwoven and dangerously close to each other.
“For LASUTH to treat, it will have to collapse one or two of the wards, which will also have the undesired attendant effect of shrinking admission capability.
“This will negatively impact on LASUTH’s ability to perform its primary tertiary function.
“However, LASUTH will continue to be able to treat complications from COVID-19 such as dialysis for renal failure and critical care.”Photo Credit: Twitter